Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/285397 
Year of Publication: 
2024
Series/Report no.: 
Texto para Discussão No. 2959
Publisher: 
Instituto de Pesquisa Econômica Aplicada (IPEA), Brasília
Abstract (Translated): 
This paper analyzed the role of the two official laboratories - Oswaldo Cruz Foundation (Fundação Oswaldo Cruz - Fiocruz) and Butantan - in facing the covid-19 pandemic in Brazil, based on the analysis of the process of building their productive and innovative capabilities and the public policies that supported them. The methodological procedures involved literature review, documentary research, and data collection. It was found that, from the identification of a mission (to ensure sufficiency in the supply of immunizers) and from policies that used mainly public procurement, a large capacity for vaccine production was developed. This, however, was not based on an endogenous innovation capacity. Fiocruz and Butantan, centennial public laboratories that provide the universal health system, whose capabilities are the result of long-term investments, were protagonists in the initiatives to face the recent health crisis. It is understood, therefore, that the State played a key role in the construction of the Brazilian Health Innovation System, as it will play it in the future in the search to overcome its weaknesses.
Subjects: 
covid-19
innovation policy
health policy
technology transfer
vaccine production
JEL: 
I18
O32
O38
Persistent Identifier of the first edition: 
Creative Commons License: 
cc-by Logo
Document Type: 
Working Paper

Files in This Item:
File
Size
1.12 MB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.